Borregaard’s Proxy Grab Is a Distraction—Watch Insider Buying Before 9 April

The headline is about a proxy grab. Chair Helge Aasen has been granted voting rights for 7.9% of the outstanding shares ahead of the 16 April AGM. On paper, that's significant power. But the real signal isn't in the proxies; it's in who actually owns the shares.

Aasen's own skin in the game is microscopic. He holds just 4,500 shares, which represents a mere 0.0001% of the company. The board's collective stake is similarly negligible. The largest holding among board members is 11,100 shares. This is a procedural formality, not a show of alignment.

The smart money here is looking at the management side. The corporate leadership's shareholdings are more substantial, with the CEO and other top executives holding tens of thousands of shares. That's where the real skin in the game resides. For now, the proxy power is a distraction. The vote at the AGM will be controlled by the board's formal authority, but the company's future is ultimately tied to the interests of those who actually own a meaningful piece of the business.

Management's Skin in the Game: Options vs. Real Equity

The board's recent option grant is a classic low-cost compensation tool, not a true alignment mechanism. The issuance of 393,000 share options at a strike price of NOK 193.27 is a future promise, contingent on the stock hitting that level. For the executives, it's a way to get paid if the company performs well, but it costs them nothing upfront. The real test of alignment is in the actual equity they own.

The largest management shareholding is 70,223 shares, held by Kristin Misund. That's a meaningful stake, but it's still a small fraction of the total float. The board's own holdings are even more negligible, with the largest being 11,100 shares. This creates a clear disconnect: the people making strategic decisions have minimal skin in the game compared to the options they are granted.

The conditions attached to the options-like the requirement to use at least 50% of proceeds to buy company stock and a three-year lock-up-add a layer of discipline. But these are safeguards, not a substitute for real equity ownership. The options themselves are a leveraged bet, with a capped gain tied to salary. For the CEO, the maximum annual gain is limited to twice their base salary. That's a ceiling, not a ceiling on ambition.

The bottom line is that the board is using options to incentivize performance without committing significant capital. The executives are being asked to align their interests with shareholders, but their financial exposure remains paper-thin compared to the potential upside. In a market where real equity ownership is the true signal of confidence, this setup suggests the smart money is still hedging its bets.

Financial Reality Check: Earnings, Guidance, and the Stock's Path

The proxy grab is a sideshow against the real story: a company navigating tough financial headwinds. Borregaard reported a 24.7% drop in earnings to NOK 620 million in 2025, even as revenue inched up. That's the kind of performance that makes investors skeptical. The board's recent option grant and proxy power are irrelevant if the core business is under pressure.

Management has tried to set a positive tone with a detailed 2026 volume guidance update. The plan calls for growth across its segments, which should provide clarity. Yet the market's reaction has been tepid. Despite the guidance, the stock's 30-day return is just 7.5%. That weak momentum suggests the market isn't buying the optimism. The stock trades at a forward P/E of 27.2, a premium that demands flawless execution of that guidance.

The valuation gap tells the real story. With a 1-year target of NOK 200, the market sees significant upside if Borregaard hits its targets. But that target is a bet on future performance, not current results. The proxy situation-where board members have minimal skin in the game-only adds to the uncertainty. It distracts from the need for the company to prove it can turn around its earnings trajectory.

In short, the proxy event is a negative distraction. The smart money is looking past the boardroom maneuvering to the financials. The stock's path will be determined by whether Borregaard can deliver on its volume guidance and, more importantly, convert that volume into the profit growth needed to justify its valuation. For now, the weak price action says the market is waiting to see proof.

Catalysts and Risks: What to Watch for Smart Money

The proxy grab is a setup for a vote, but the real action is elsewhere. The smart money is looking past the boardroom maneuvering to concrete events that will prove whether Borregaard's story is credible or a distraction.

The key catalyst is the 29 April earnings report. This will be the first real test of the company's 2026 volume guidance update. The market has already shown it needs proof, with the stock's 30-day return stuck at just 7.5% despite the guidance. The April report must show volume growth translating into profit, not just top-line numbers. Any stumble here would validate the skepticism around the premium valuation and the board's minimal skin in the game.

A major risk is the company's recent NOK 245 million impairment on its bio-based start-up investments. That write-down signals execution risk in its innovation pipeline. It's a tangible cost for past bets that didn't pay off, which could pressure future R&D spending or capital allocation. For a company trading at a forward P/E of 27.2, the market will be watching for any sign that this kind of loss is becoming a recurring theme.

Finally, watch the days leading up to the record date for the AGM on 9 April. The board has granted itself voting rights for 7.9% of shares, but the real insider sentiment will be in the filings. Any significant buying or selling by executives or board members in the days before that date would be a stronger signal than any proxy power. Given the minimal equity stakes we've seen, a flurry of activity could reveal who truly believes in the turnaround story.

The bottom line is that the proxy situation is a sideshow. The smart money is focused on the April earnings, the health of the innovation portfolio, and the actual trading behavior of those with real capital at risk. The vote on 16 April will be a formality; the real vote is in the financials and the insider wallets.